5,5-dimethyl-8-phenyl-13-[3-(3-pyridin-2-ylphenoxy)phenyl]-1,8-naphthyridino[3,2-c]carbazole
C43H32N4O — CID 140954421
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5,5-dimethyl-8-phenyl-13-[3-(3-pyridin-2-ylphenoxy)phenyl]-1,8-naphthyridino[3,2-c]carbazole
5,5-dimethyl-8-phenyl-13-[3-(3-pyridin-2-ylphenoxy)phenyl]-1,8-naphthyridino[3,2-c]carbazole (PubChem CID 140954421) has the molecular formula C43H32N4O and a molecular weight of 620.76 g/mol. Its IUPAC name is 5,5-dimethyl-8-phenyl-13-[3-(3-pyridin-2-ylphenoxy)phenyl]-1,8-naphthyridino[3,2-c]carbazole.
Molecular Properties
| Compound Name | 5,5-dimethyl-8-phenyl-13-[3-(3-pyridin-2-ylphenoxy)phenyl]-1,8-naphthyridino[3,2-c]carbazole |
|---|---|
| PubChem CID | 140954421 |
| Molecular Formula | C43H32N4O |
| Molecular Weight | 620.76 g/mol |
| Exact Mass | 620.26 |
| IUPAC Name | 5,5-dimethyl-8-phenyl-13-[3-(3-pyridin-2-ylphenoxy)phenyl]-1,8-naphthyridino[3,2-c]carbazole |
| SMILES | CC1(C)c2cccnc2N(c2cccc(Oc3cccc(-c4ccccn4)c3)c2)c2c1ccc1c2c2ccccc2n1-c1ccccc1 |
| InChI | InChI=1S/C43H32N4O/c1-43(2)35-23-24-39-40(34-19-6-7-22-38(34)46(39)30-14-4-3-5-15-30)41(35)47(42-36(43)20-12-26-45-42)31-16-11-18-33(28-31)48-32-17-10-13-29(27-32)37-21-8-9-25-44-37/h3-28H,1-2H3 |
| InChIKey | WNXNMOOOIUXVMX-UHFFFAOYSA-N |
| XLogP | 11.14 |
| TPSA | 43.18 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 48 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 620.76 |
| LogP ≤ 5 | 11.14 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 140954421 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.